Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00074789 · ClinicalTrials.gov registry record · Phase 2

Reducing Symptoms of Depression in Low-Income Mothers

A Phase 2 study of Depression, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
Phase 2
Development phase
226
Enrollment target
6
Study locations

NCT00074789 is a Phase 2 study of Depression that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 226 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (71% lower). The trial reports 6 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00074789, a Phase 2 study of Depression, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
Phase 2
Development phase
226 participants
Enrollment target
6
Study locations

Study Summary

This study will test the effectiveness of a short-term intervention in treating depressed young mothers with young children enrolled in Early Head Start Programs.

Conditions Studied

Interventions

  • BEHAVIORAL Modified Interpersonal Therapy
  • BEHAVIORAL Attention control/usual care

Study Locations (6)

North Carolina

  • Asheville City Schools Preschool-Early Head Start Program - Asheville
  • Chapel Hill Training Outreach Project, Inc. Early Head Start - Chapel Hill
  • University of North Carolina, Chapel Hill - Chapel Hill
  • W.A.G.E.S., Inc. Early Head Start Program - Goldsboro
  • United Child Development Services, Inc. Early Head Start - Greensboro

New York

  • P.E.A.C.E, Inc. Early Head Start - Syracuse

Trial Details

FieldValue
Enrollment Target 226 participants
Start Date 2003-06
Est. Completion 2009-01
Phase Phase 2

What the Registry Record Tells You About NCT00074789

The ClinicalTrials.gov registry entry for NCT00074789 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 226 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (71% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Modified Interpersonal Therapy is the first listed.

NCT00074789 reports 6 study locations spanning 2 distinct geographic areas - top geographies include North Carolina, New York.

Frequently Asked Questions

What is clinical trial NCT00074789 about?

NCT00074789 is a clinical study titled "Reducing Symptoms of Depression in Low-Income Mothers". This study will test the effectiveness of a short-term intervention in treating depressed young mothers with young children enrolled in Early Head Start Programs.

What is the current status of trial NCT00074789?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 226 participants. The study started on 2003-06. Estimated completion is 2009-01.

What conditions does trial NCT00074789 study?

This clinical trial studies the following conditions: Depression.

What interventions are being tested in trial NCT00074789?

The interventions under investigation include: Modified Interpersonal Therapy (BEHAVIORAL), Attention control/usual care (BEHAVIORAL).

Who is sponsoring clinical trial NCT00074789?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00074789 being conducted?

This trial has 6 study locations across New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.